Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Colgate-Palmolive (CL)

Colgate-Palmolive reports 4Q 2023 sales up 7.0% and EPS of $0.87; full-year EPS $2.77

Positive Impact 3 of 5 earnings Written later

Colgate-Palmolive reported fourth-quarter 2023 net sales of $4,950 million, up 7.0% from a year earlier, and GAAP diluted EPS of $0.87 versus $0.01, which lapped 2022 impairment charges. For full year 2023, net sales rose 8.5% to $19,457 million and GAAP diluted EPS rose 30% to $2.77. The company guided 2024 net sales growth of 1% to 4% and double-digit GAAP EPS growth.

Key points

  • 4Q 2023 net sales $4,950 million, up 7.0%; diluted EPS $0.87 versus $0.01 in 4Q 2022
  • Full-year 2023 net sales $19,457 million, up 8.5%; diluted EPS $2.77 versus $2.13
  • 2024 guidance: net sales growth of 1% to 4% and double-digit GAAP EPS growth, including a low-single-digit negative foreign exchange impact

The filing

CompanyColgate-Palmolive (CL)
Form8-K, current report
Filed with the SECJan 26, 2024, 8:00 AM ET
Accession number0001157523-24-000119

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:21 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on January 26, 2024.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.